Curaleaf Signs Agreement with WB Canna Co. & Wellness

WAKEFIELD, Mass. – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) an international provider of consumer CBD and hemp products, today announced that its Select CBD and Curaleaf Hemp products will become available for the first time in the Caribbean market thanks to a new distribution agreement with WB Canna Co. & Wellness. This agreement will bring Curaleaf’s lineup of products from its eponymous Hemp and Select CBD product lines to customers in, and traveling throughout, the U.S. Virgin Islands, Puerto Rico, Aruba, Bermuda, Barbados, Cayman, Costa Rica, Guatemala, Jamaica, and Saint Maarten, as well as additional markets in Latin America, travel retail, and the cruise and diplomatic channel.

WB Canna Co. & Wellness is a wholly owned subsidiary of Miami-based WEBB Banks, the leading premium wine and spirits distributor in the Caribbean and one of the first companies in the region focused on distribution of top-quality CBD and wellness products. The distribution relationship combines Curaleaf’s expertise in creating high-quality non-psychoactive hemp products with WB Canna Co.’s ability to navigate the legal and compliance needs across the fragmented geography of the Caribbean, bringing operating efficiencies that will drive further accessibility to Curaleaf’s family of CBD products.

Curaleaf Hemp offers a broad range of CBD products with consumer-friendly formats and price points to select retailers throughout the U.S. A collection of all-new Select CBD products that feature minor cannabinoids like CBN and CBG, are slated to debut in April. All Curaleaf and Select CBD products are subjected to stringent industry testing practices.

“We are committed to setting the highest possible standards for product quality and accessibility at Curaleaf, and we are thrilled to expand the reach of our award-winning CBD products to retail stores in the Caribbean through a distribution partner like WB Canna Co. It continues to be of utmost importance that we’re able to provide consumers with reliable access to the products they know and love,” said Patrick Larkin, SVP of Sales at Curaleaf.

“We believe that consumer demand for high-quality CBD products will continue to grow year-over-year, and we remain laser-focused on building brand recognition and brand loyalty,” said Joseph Gennaro, VP of CBD, Health & Wellness at Curaleaf. “Consequently, our agreement with WB Canna Co. marks a key inflection point in the go-to-market strategy for our CBD business and shows our commitment to achieving international growth.”

“In the short time since launching WB Canna Co. and Wellness early last year, we’ve seen incredible interest and excitement for high-quality CBD and wellness products throughout the Caribbean and Latin America,” said Phillip Jarrell, COO of WB Canna Co. & Wellness. “We’re very proud to add Curaleaf to our growing portfolio and introduce their popular and innovative products to consumers across the region.”

CBD products that are derived from hemp contain less than 0.3% THC and have been legal at the federal level since the passing of the Farm Bill in 2018. As a precaution, we recommend researching the CBD laws and regulations of your destination, as well as any countries or states you are traveling through en route to your destination. You should also thoroughly understand the products in your possession, and whether they contain any THC or are purely CBD. TSA rules apply. The statements above have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

FORWARD-LOOKING STATEMENTS
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning Curaleaf’s business relationship with WB Canna Co. & Wellness and hemp products related thereto. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed March 9, 2022, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

(This information is primarily sourced from Curaleaf Holdings, Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).